Intratympanic lidocaine instillation for Meniere's disease

被引:0
|
作者
Verdonck, J. [1 ]
Desloovere, C. [1 ]
机构
[1] Katholieke Univ Leuven Hosp, Dept Otorhinolaryngol Head & Neck Surg, B-3000 Louvain, Belgium
来源
B-ENT | 2011年 / 7卷 / 03期
关键词
Meniere's disease; vertigo; lidocaine; treatment; labyrinth anaesthesia; VESTIBULAR NERVE-SECTION; GENTAMICIN; TINNITUS; RATS;
D O I
暂无
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Intratympanic lidocaine instillation for Meniere's disease. Objectives: We studied the role of intratympanic lidocaine instillation as part of the treatment for vertigo in Meniere's disease. Methodology: We retrospectively analyzed 40 patients who underwent 74 labyrinth anaesthesias in our center between 1996 and 2006. We studied the attack-free period after instillation, the effect of repetitive procedures and the efficacy according to the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) (1995) criteria. Results: Labyrinth anaesthesia was effective in 70% of the studied procedures. If effective, the mean duration of the attack-free period was 12.6 months. Repetition was effective in 80.7% of the procedures if the previous procedure was effective as well. Two years after treatment 21 patients had AAO-HNS functional levels of 1 or 2 and 23 patients were class A or B. Conclusion: Labyrinth anaesthesia is an effective treatment for Meniere's disease and a useful tool for the control of symptoms. Repetitive instillation is effective especially when the previous instillation was also effective.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [1] Intratympanic gentamicin for intractable Meniere's disease
    Perez, N
    Martín, E
    García-Tapia, R
    LARYNGOSCOPE, 2003, 113 (03): : 456 - 464
  • [2] Intratympanic gentamicin for Meniere's disease
    Webster, Katie E.
    Galbraith, Kevin
    Lee, Ambrose
    Harrington-Benton, Natasha A.
    Judd, Owen
    Kaski, Diego
    Maarsingh, Otto R.
    MacKeith, Samuel
    Ray, Jaydip
    Van Vugt, Vincent A.
    Burton, Martin J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (02):
  • [3] Low Dose Intratympanic Gentamicin in Meniere's Disease
    Faizal, Bini
    Rajan, Afsha
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 1) : 320 - 325
  • [4] Systematic review of intratympanic gentamicin in Meniere's disease
    Diamond, C
    O'Connell, DA
    Hornig, JD
    Liu, R
    JOURNAL OF OTOLARYNGOLOGY, 2003, 32 (06): : 351 - 361
  • [5] Control of vertigo in Meniere's disease by intratympanic dexamethasone
    Weckel, A.
    Marx, M.
    Esteve-Fraysse, M. -J.
    EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2018, 135 (01) : 7 - 10
  • [6] Intratympanic Corticosteroid Perfusion in the Therapy of Meniere's Disease
    Sankovic-Babic, Snezana
    Kosanovic, Rade
    Ivankovic, Zoran
    Babac, Snezana
    Tatovic, Milica
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2014, 142 (5-6) : 291 - 295
  • [7] Intratympanic gentamicin for the treatment of unilateral Meniere's disease
    Kaplan, DM
    Nedzelski, JM
    Chen, JM
    Shipp, DB
    LARYNGOSCOPE, 2000, 110 (08): : 1298 - 1305
  • [8] Intratympanic dexamethasone injections for refractory Meniere' s disease
    Ren, Hongmiao
    Yin, Tuanfang
    Lu, Yongde
    Kong, Weijia
    Ren, Jihao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 6016 - 6023
  • [9] Hearing loss following intratympanic instillation of gentamicin for the treatment of unilateral Meniere's disease
    Kaplan, DM
    Nedzelski, JM
    Al-Abidi, A
    Chen, JM
    Shipp, DB
    JOURNAL OF OTOLARYNGOLOGY, 2002, 31 (02): : 106 - 111
  • [10] Long-term vertigo control in patients after intratympanic gentamicin instillation for Meniere's disease
    Bodmer, Daniel
    Morong, Sharon
    Stewart, Craig
    Alexander, Ashlin
    Chen, Joseph M.
    Nedzelski, Julian M.
    OTOLOGY & NEUROTOLOGY, 2007, 28 (08) : 1140 - 1144